• GMP-compliant cell culture medium optimises API manufacture
    Bottle of StemFit Basic04 CT.
  • Colony of iPSCs grown using StemFit Basic04 CT.


GMP-compliant cell culture medium optimises API manufacture

Apr 30 2024

AMSBIO has unveiled an upgraded GMP-compliant version of its animal-origin-free, chemically defined StemFit™ iPSC expansion medium. StemFit™ Basic04 CT is engineered to enhance the growth and pluripotency of induced pluripotent stem cells (iPSC) while meeting the stringent Good Manufacturing Practice (GMP) standards for Active Pharmaceutical Ingredients (API).

With its superior iPSC performance, StemFit™ Basic04 CT facilitates expansion and sustains long-term genetic stability, optimising single-cell passaging for large-scale stem cell production. The manufacturing and quality control of this exciting new product are managed in strict accordance with GMP standards.

Each bottle of StemFit™ Basic04 CT is accompanied by a certificate of analysis and all necessary documentation, ensuring a seamless transition to clinical applications. Aisha Amari, Business Development specialist at AMSBIO, emphasised the significance of iPSCs in revolutionising cellular medicines and highlighted the pivotal role of GMP-compliant StemFit™ Basic04 CT in iPSC manufacturing for cell therapy.

Amari stated: "Using StemFit™, we hope researchers can further advance translational research, drug discovery and development and help bring high-quality iPSC based- therapies from bench to bedside."

More information online

Digital Edition

Lab Asia 31.3 June 2024

June 2024

Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - UV-Vis and fluorescence spectroscopy illumina...

View all digital editions



Jun 26 2024 Tokyo, Japan

Asia Labex

Jul 03 2024 Gandhinagar, India

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

View all events